Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,493 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase I clinical trial of ormaplatin (tetraplatin, NSC 363812).
O'Rourke TJ, Weiss GR, New P, Burris HA 3rd, Rodriguez G, Eckhardt J, Hardy J, Kuhn JG, Fields S, Clark GM, et al. O'Rourke TJ, et al. Among authors: hardy j. Anticancer Drugs. 1994 Oct;5(5):520-6. doi: 10.1097/00001813-199410000-00002. Anticancer Drugs. 1994. PMID: 7858283 Clinical Trial.
Phase I clinical investigation of amonafide.
Saez R, Craig JB, Kuhn JG, Weiss GR, Koeller J, Phillips J, Havlin K, Harman G, Hardy J, Melink TJ, et al. Saez R, et al. Among authors: hardy j. J Clin Oncol. 1989 Sep;7(9):1351-8. doi: 10.1200/JCO.1989.7.9.1351. J Clin Oncol. 1989. PMID: 2549205 Clinical Trial.
How nephrotoxic is carboplatin?
Hardy JR, Tan S, Fryatt I, Wiltshaw E. Hardy JR, et al. Br J Cancer. 1990 Apr;61(4):644. doi: 10.1038/bjc.1990.143. Br J Cancer. 1990. PMID: 2184881 Free PMC article. No abstract available.
Carboplatin dose optimization.
Pinkerton CR, Hardy JR. Pinkerton CR, et al. Among authors: hardy jr. J Clin Oncol. 1990 Jul;8(7):1283-5. doi: 10.1200/JCO.1990.8.7.1283. J Clin Oncol. 1990. PMID: 1694237 No abstract available.
African ancestry neurodegeneration risk variant disrupts an intronic branchpoint in GBA1.
Jerez PÁ, Wild Crea PA, Ramos DM, Gustavsson EK, Radefeldt M, Makarious MB, Ojo OO, Billingsley KJ, Malik L, Daida K, Bromberek S, Hu C, Schneider Z, Surapaneni AL, Stadler J, Rizig M, Morris HR, Pantazis CB, Leonard HL, Screven L, Qi YA, Nalls MA, Bandres-Ciga S, Hardy J, Houlden H, Eng C, Burchard EG, Kachuri L; Global Parkinson’s Genetics Program (GP2); Singleton AB, Fischer S, Bauer P, Reed X, Ryten M, Beetz C, Ward M, Okubadejo NU, Blauwendraat C. Jerez PÁ, et al. Among authors: hardy j. medRxiv [Preprint]. 2024 Feb 24:2024.02.20.24302827. doi: 10.1101/2024.02.20.24302827. medRxiv. 2024. Update in: Nat Struct Mol Biol. 2024 Dec;31(12):1955-1963. doi: 10.1038/s41594-024-01423-2 PMID: 39802803 Free PMC article. Updated. Preprint.
3,493 results